Outcome and Tunnel Widening After ACL Reconstruction: Comparison of Aperture and Cortical Fixation

January 15, 2013 updated by: Dr. René El Attal, Medical University Innsbruck

Clinical Outcome and Tunnel Widening After Hamstring Anterior Cruciate Ligament Reconstruction: A Prospective Randomized Computed Tomography - Based Trial Comparing Aperture With Cortical Fixation

Background:

Failure of graft incorporation and tunnel widening (TW) after anterior cruciate ligament (ACL) reconstruction has been frequently reported in the literature. The etiology of TW is still not fully understood.

Patients and Methods:

This is a prospective randomized study including 60 patients, conducted in a Level I trauma center in Innsbruck, Austria. The study protocol was approved by the hospital ethics committee. This study is planned and conducted following the Consolidated Standards on Reporting Trials (CONSORT) guidelines. Aperture fixation is performed using BioComposite interference screws (Arthrex, Naples, FL). Extracortical fixation is performed using the ACL Tightrope (Arthrex, Naples, FL). TW is measured on CT scan postoperative, after 6 and 24 months. Clinical outcome is determined at 1, 2 after reconstruction, IKDC with KOOS Knee-related QoL subscale, Lysholm, Tegner Activity scores, hop tests and KT-1000 measurements are performed.

Hypothesis:

The purpose of this randomized controlled trail is to determine the influence of two different fixation methods on TW and clinical outcome after anatomic ACL reconstruction using hamstring graft in young and active patients.

Study Overview

Detailed Description

The study is a randomized controlled clinical trial and will be conducted at the Traumasurgery Innsbruck. Two different surgical methods are tested: ACL Tightrope reconstruction VS Biocomposite interference screws.

Following eligibility criteria have to be met:

  1. Age 18 -40 years
  2. ACL insufficiency diagnosed by clinical examination (positive Lachman test and/or pivot shift test) and MRI (complete tear)
  3. Not more than 12 month after trauma to the knee
  4. Tegner Score 5 to 10

Not eligible if:

  1. Earlier major knee injury to the index knee
  2. Previous knee surgery (except diagnostic arthroscopy) to index knee
  3. Associated knee fractures
  4. Associated PCL injury, complete MCL or LCL tear
  5. Concomitant severe injury to contra-lateral knee at time of assessment
  6. Injury to the lateral/posterolateral ligament complex with increased laxity (positive dial test and external rotation thigh foot angle test),
  7. Pregnancy and scope to become within next time
  8. A history of deep vein thrombosis (DVT) or a disorder of the coagulative system
  9. Claustrophobia
  10. General systemic disease affecting physical function, any other condition or treatment interfering with the completion of the trial, including patients with metal devices, pacemaker or motion disorders
  11. Chronic systemic use of steroids

Following inclusion and exclusion criteria have to be met:

Inclusion:

  1. The ACL injury can be either "isolated" or combined with one or several of the following injuries visualized on MRI and/or arthroscopy:

    • A meniscus tear that is either left untreated or treated with a partial resection
    • A small, stable meniscus tear treated with fixation, but fixation not interfering with the rehabilitation protocol
    • Cartilage changes verified on MRI with arthroscopically determine intact surface
  2. A radiographic examination with normal joint status or combined with either one of the following finding:

    • A small avulsed fragment located laterally, usually described as a Second fracture
    • JSN grade 1 or osteophytes grade 1 as determined by the OARSI atlas (Altman et al. 1995)
  3. Agreement to participate in the study and signed informed consent prior to inclusion.

Exclusion:

1.Presence of one of the following associated injuries to the index knee as visualized on MRI and/or arthroscopy:

  • An unstable longitudinal meniscus tear that requires repair and where the following postoperative treatment (i.e. bracing and limited ROM) interferes with the rehabilitation protocol
  • Bi-compartmental extensive meniscus resection
  • A cartilage injury representing a full thickness loss down to bone
  • A total rupture of MCL/LCL as visualized on MRI

A power analysis was performed, estimating that a minimum of 34 patients (17 in each group) would be required to obtain a power more than 80%.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tyrol
      • Innsbruck, Tyrol, Austria, 6020
        • Recruiting
        • Medical University Innsbruck (Traumasurgery)
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Raul Mayr, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The ACL injury can be either "isolated" or combined with one or several of the following injuries visualized on MRI and/or arthroscopy:

    • A meniscus tear that is either left untreated or treated with a partial resection
    • A small, stable meniscus tear treated with fixation, but fixation not interfering with the rehabilitation protocol
    • Cartilage changes verified on MRI with arthroscopically determine intact surface
  2. A radiographic examination with normal joint status or combined with either one of the following finding:

    • A small avulsed fragment located laterally, usually described as a Second fracture
    • JSN grade 1 or osteophytes grade 1 as determined by the OARSI atlas (Altman et al. 1995)
  3. Agreement to participate in the study and signed informed consent prior to inclusion.

Exclusion Criteria:

1.Presence of one of the following associated injuries to the index knee as visualized on MRI and/or arthroscopy:

  • An unstable longitudinal meniscus tear that requires repair and where the following postoperative treatment (i.e. bracing and limited ROM) interferes with the rehabilitation protocol
  • Bi-compartmental extensive meniscus resection
  • A cartilage injury representing a full thickness loss down to bone
  • A total rupture of MCL/LCL as visualized on MRI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Biocomposite interference screw
Thirty patients treated with ACL reconstruction and graft fixation is performed using Biocomposite interference screw on tibial and femoral side. Patients are randomized to one of the two study arms.
Other: Extracortical ACL Tightrope fixation
Thirty patients treated with ACL reconstruction and graft fixation is performed using extracortical ACL Tightrope fixation on tibial and femoral side. Patients are randomized to one of the two study arms.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of tunnel volume and diameter from baseline up to 2 year follow up
Time Frame: 1-2 days before (knee) operation, 6 months FU, 2 year FU
CT tunnel measurements are conducted. Tunnel volume are calculated by CT volumetry measured in mm³ and tunnel diameter is measured in mm.
1-2 days before (knee) operation, 6 months FU, 2 year FU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical outcome: international knee score evaluating objective and subjective knee outcome variables
Time Frame: 1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU

Clinical outcome measured by IKDC (INTERNATIONAL KNEE DOCUMENTATION COMMITTEE) Subjective questionnaire (symptoms, sports activity, knee function): scaled from 0-100.

Objective evaluation form (radiological assessment of cartilage and menisci, functional knee examination, range of motion): scaled A-D

1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome: influence on quality of life after knee ACL reconstruction
Time Frame: 1-2 days before (knee)operation, 6 month FU, 1 year FU, 2year FU
Clinical outcome measured by KOOS Knee related QoL subscale
1-2 days before (knee)operation, 6 month FU, 1 year FU, 2year FU
Clinical outcome: subjective evaluation of knee function
Time Frame: 1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome measured by Lysholm Score: subjective questionnaire
1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome: return to sports activity
Time Frame: 1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome measured by Tegner Activity scores: sports activity level
1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome: strength in single leg jumping after ACL reconstruction
Time Frame: 1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Single leg hop test measured in cm. Comparing the injured and healthy knee.
1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome: objective knee anterior stability
Time Frame: 1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU
Clinical outcome measured by KT1000 arthrometer measurements in mm.
1-2 days before (knee)operation, 6 months FU, 1 year FU, 2 year FU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rene El Attal, Dr., Medical University Innsbruck (Traumasurgery)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Anticipated)

January 1, 2016

Study Completion (Anticipated)

January 1, 2016

Study Registration Dates

First Submitted

December 4, 2012

First Submitted That Met QC Criteria

December 19, 2012

First Posted (Estimate)

December 24, 2012

Study Record Updates

Last Update Posted (Estimate)

January 16, 2013

Last Update Submitted That Met QC Criteria

January 15, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • ACL Tightrope vs. Biocomposite

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Outcome

Clinical Trials on Biocomposite interference screw

3
Subscribe